A new study has revealed that even short-term usage of common acid-reducing heartburn drugs can increase the risk of hip fractures.
The study, presented at this year's Digestive Disease Week 2009, suggests that older patients should avoid using proton pump inhibitors drugs to spare their bones from fractures.
FDA Concludes No Heart Attack Risk from Heartburn Drugs
The US FDA officials said Monday they found no evidence of increased heart risks from popular heartburn drugs Prilosec and Nexium.
The US FDA officials said Monday they found no evidence of increased heart risks from popular heartburn drugs Prilosec and Nexium.
Others include popular brands such as Nexium, Prilosec, Protonix, and Aciphex.
"The increased risk with short-term use of acid-suppressing drugs suggests that even relatively brief periods of use may be associated with increased risk of hip fractures," said study's lead author Dr. Douglas Corley.
Heartburn drugs linked to bacterial diarrhea
People popping popular prescription heartburn drugs such as Prilosec, Prevacid and Nexium may be more prone to a potentially dangerous diarrhea caused by the bug Clostridium difficile, research says.
People popping popular prescription heartburn drugs such as Prilosec, Prevacid and Nexium may be more prone to a potentially dangerous diarrhea caused by the bug Clostridium difficile, research says.
They found that people aged fifty to fifty-nine who had been on proton pump inhibitors for more than two years had the biggest increase in fracture risk with taking the drugs.
Advertisement
AstraZeneca Agrees Deal With Ranbaxy Over Stomach Ulcers, Heartburn Drug
Anglo-Swedish pharmaceuticals giant AstraZeneca said Tuesday it had agreed to a deal that would enable top Indian generic drug firm Ranbaxy to produce its own version of heartburn
Anglo-Swedish pharmaceuticals giant AstraZeneca said Tuesday it had agreed to a deal that would enable top Indian generic drug firm Ranbaxy to produce its own version of heartburn
TAN
